Clinical review: Safety and efficacy comparison between sulfonylureas and dipep-tidyl peptidase-4 inhibitors as second-line therapies in type 2 diabetes mellitus
Research output: Contribution to journal › Review article › peer-review
3Scopus
citations
Fingerprint
Dive into the research topics of 'Clinical review: Safety and efficacy comparison between sulfonylureas and dipep-tidyl peptidase-4 inhibitors as second-line therapies in type 2 diabetes mellitus'. Together they form a unique fingerprint.
Medicine and Dentistry
Pharmacology, Toxicology and Pharmaceutical Science